News & Events

February 23, 2021

BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 22, 2021

BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 16, 2021

BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

February 16, 2021

BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

January 25, 2021

BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC

CRESSKILL, N.J. and JERUSALEM, Israel, Jan. 25, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 18, 2020

BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights

CRESSKILL, N.J. and JERUSALEM, Israel, November 18, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 11, 2020

BrainsWay Announces Publication of New Real-World OCD Data for its Deep TMS System in Journal of Psychiatric Research

Additional data on first non-invasive medical device cleared by the FDA for OCD demonstrated that 73%...

November 4, 2020

BrainsWay to Report Third Quarter 2020 Financial Results and Operational Highlights on November 18, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, November 4, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 2, 2020

BrainsWay to Participate in Two Upcoming Investor Conferences

CRESSKILL, N.J. and JERUSALEM, Israel, November 2, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

October 13, 2020

BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)

In conjunction with OCD Awareness Week, BrainsWay partners with mental health influencers and patients...

October 6, 2020

BrainsWay Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session

Deep TMS highlighted in 10 presentation posters at annual session

September 8, 2020

BrainsWay to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

CRESSKILL, N.J. and JERUSALEM, Israel, September 8, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

September 2, 2020

BrainsWay Announces Presentations at Upcoming Investor Conferences

CRESSKILL, N.J. and JERUSALEM, Israel, September 2, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

August 24, 2020

BrainsWay Receives FDA Clearance for Smoking Addiction in Adults

Company Intends to Execute a Controlled U.S. Market Release in Early 2021 This is the Company’s third...

August 12, 2020

BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights

CRESSKILL, N.J. and JERUSALEM, Israel, August 12, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

July 29, 2020

BrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...